Skip to main content
University of Michigan Innovation Partnerships
University of Michigan Innovation Partnerships

Portfolio

Go Sevare

Software that detects faults from sensors and low-level board components
(2020)

GuangZhou Boxin Medical

Two-phase atherectomy for removal of atherosclerotic plaque
(2020)

Labyrinth Biotech Inc

Microfluidic technology for the isolation and capture of circulating tumor cells for research purposes and clinical diagnosis
(2020)

LynxDX, Inc

Biotechnology startup using prostate cancer diagnostic assay to measure levels of cancer specific genes in the urine. Additionally focused on scaling COVID-19 testing
(2020)

MONSTR Sense Technologies

Ultrafast and coherent spectroscopy microscopes for semiconductor defect inspection and advanced research
(2020)

Nanjing Novall Medical Co Ltd

Nitric oxide releasing medical device technology
(2020)

Novlead Biotech

Medical devices that release nitric oxide to treat persistent pulmonary hypertension of the newborn
(2020)

NuBundle, Inc.

Suite of software and services for patients undergoing assisted reproduction treatment
(2020)

OntMed

Medical ontology and classification system used to improve search, interogation and analysis of a variety of medical data
(2020)

Photon Semantics

Computer vision neural network enabling material sensing within optical sensors including LIDAR and cameras
(2020)

PTM Therapeutics

Antibody therapeutic for the treatment of inflammatory bowel disease
(2020)

Refraction AI, Inc

Robotic platform for providing safe and scalable goods delivery in urban areas
(2020)

S3D Precision Dispensing, Inc

Enabling digital manufacturing; dispensing lubricants, OLED materials and bio-fluids with micron-scale features onto existing surfaces
(2020)

Smart Production Systems

Automating managerial decision-making on the factory floor
(2020)

Zakuro

Safer solid-state batteries with double the energy density of Li-ion batteries
(2020)

Angio Insight

Automated analysis of angiograms to augment clinical decisions in managing coronary artery disease
(2019)

Applied Morphomics Inc

Applied Morphomics, Inc. is a biomarker technology and development company targeting assessment of body factors essential for delivering precision medicine.
(2019)
1 4 5 6 7 8 9 10 21